Nabta Health, the Dubai-based hybrid healthcare company positions women not as a niche market but as the starting point for a ...

In a pivotal trial of Science’s Prima BCI, 84% of patients impacted by dry AMD were able to read again once fitted with the technology.

Cognita has received the FDA breakthrough device designation for the Chest X-Ray (CXR) model across multiple critical indications.

Out of the diabetes patients surveyed, 46% said they would feel more in control of their disease in everyday life if they could identify trends before they turn into problems.

Neuspera Medical has reported encouraging 12-month pivotal trial results for its iSNM, Neuspera SNM, in patients with UUI.

With a pivotal trial readout for Cognito’s Spectris due later this year, the company anticipates launching the Alzheimer’s ...

Airiver Medical has secured the US FDA breakthrough device designation for its pulmonary DCB intended for the treatment of ...

Philips has unveiled its next-generation radiology CT system, Rembra, to address the challenges faced by acute and high-demand imaging settings.

Droplet Biosciences has reported a reduction in genomic analysis turnaround time for residual cancer detection by adopting GPU-accelerated workflows using NVIDIA Parabricks software.

PathAI has received the US FDA breakthrough device designation for PathAssist Derm, an AI-powered dermatopathology workflow solution.

RadNet will now offer AI-driven services across screening, detection, interpretation and follow-up across multiple disease areas.

Pharma companies are increasingly combining the strengths of pharmaceutical and digital health interventions to improve outcomes.